We are live on ! Find out more
GHA

GW Henssler & Associates Portfolio holdings

AUM $2.25B
1-Year Est. Return 19.46%
This Fund
S&P 500
This Quarter Est. Return
+3.83%
1 Year Est. Return
+19.46%
3 Year Est. Return
+62.37%
5 Year Est. Return
+80.78%
10 Year Est. Return
+246.91%
AUM
$1.1B
AUM Growth
+$13.3M
Cap. Flow
-$24.2M
Cap. Flow %
-2.19%
Top 10 Hldgs %
27.52%
Holding
243
New
37
Increased
59
Reduced
88
Closed
42

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$16.6M
2
MET icon
MetLife
MET
+$12.3M
3
TROW icon
T. Rowe Price
TROW
+$11M
4
SCHW
Charles Schwab
SCHW
+$10.8M
5
BLK icon
Blackrock
BLK
+$7.3M

Sector Composition

Rank Sector Weight
1 Healthcare 12.28%
2 Consumer Staples 11.92%
3 Technology 10.82%
4 Financials 9.16%
5 Energy 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
26
Intel
INTC
$513B
$15.4M 1.39%
321,404
-116,007
-27% -$5.75M
KR icon
27
Kroger
KR
$34.8B
$15.1M 1.37%
697,291
+453,241
+186% +$11M
RDS.A
28
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$15M 1.36%
230,300
+7,500
+3% +$480K
SO icon
29
Southern Company
SO
$107B
$14.9M 1.35%
270,030
+7,033
+3% +$377K
VLO icon
30
Valero Energy
VLO
$85.9B
$14.7M 1.33%
171,164
+7,036
+4% +$581K
HRL icon
31
Hormel Foods
HRL
$13.8B
$14.5M 1.31%
356,892
-6,373
-2% -$258K
WM icon
32
Waste Management
WM
$91B
$14.5M 1.31%
125,261
-762
-0.6% -$82.7K
USB icon
33
US Bancorp
USB
$99.6B
$13.8M 1.25%
263,801
-3,817
-1% -$197K
CHRW icon
34
C.H. Robinson
CHRW
$17.5B
$13.7M 1.24%
162,019
+297
+0.2% +$25K
NVO
35
Novo Nordisk
NVO
$209B
$13.6M 1.23%
531,274
+20,168
+4% +$498K
BIL icon
36
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
$13.4M 1.22%
146,713
-8,339
-5% -$763K
MCD icon
37
McDonald's
MCD
$195B
$12.4M 1.12%
59,537
-2,263
-4% -$448K
GILD icon
38
Gilead Sciences
GILD
$165B
$12.3M 1.11%
182,157
+1,708
+0.9% +$112K
CTSH icon
39
Cognizant
CTSH
$26B
$12.1M 1.09%
190,411
+2,663
+1% +$175K
QUAL icon
40
iShares MSCI USA Quality Factor ETF
QUAL
$47.9B
$12M 1.09%
131,148
+64,053
+95% +$5.76M
XEL icon
41
Xcel Energy
XEL
$48.8B
$12M 1.09%
201,602
+6,405
+3% +$368K
AJG icon
42
Arthur J. Gallagher & Co
AJG
$63.6B
$11.8M 1.07%
134,349
+989
+0.7% +$82.5K
LMT icon
43
Lockheed Martin
LMT
$136B
$11.5M 1.04%
31,635
+275
+0.9% +$92K
VFC icon
44
VF Corp
VFC
$5.89B
$11.4M 1.03%
130,839
-13,574
-9% -$1.17M
D icon
45
Dominion Energy
D
$59.3B
$11.4M 1.03%
147,382
+6,915
+5% +$527K
PNW icon
46
Pinnacle West Capital
PNW
$12.2B
$10.9M 0.98%
115,517
+2,845
+3% +$271K
MMM icon
47
3M
MMM
$94.3B
$10.5M 0.95%
72,146
-114
-0.2% -$17.5K
MO icon
48
Altria Group
MO
$114B
$10.1M 0.91%
213,159
+4,799
+2% +$251K
NVS icon
49
Novartis
NVS
$297B
$9.91M 0.9%
108,539
+287
+0.3% +$24.3K
PM icon
50
Philip Morris
PM
$295B
$9.83M 0.89%
125,218
+3,211
+3% +$265K

Similar funds

GW Henssler & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, GW Henssler & Associates held 243 positions worth $1.1B, up 1.2% from $1.09B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

GW Henssler & Associates's Q2 2019 filing shows 37 new, 59 increased, 88 reduced and 42 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 27,739 shares worth $8.68M. The largest sale was Celgene Corp, an estimated $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Consumer Staples and Technology.

  • GW Henssler & Associates's largest Q2 2019 buy was Regeneron Pharmaceuticals: 27,739 shares worth $8.68M.
  • GW Henssler & Associates added most to State Street Utilities Select Sector SPDR ETF in Q2 2019, an estimated $11.5M increase.
  • GW Henssler & Associates's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $16.6M.
  • GW Henssler & Associates fully exited NIC Inc in Q2 2019, selling an estimated $1.2M.
  • GW Henssler & Associates's ten largest holdings make up 28% of its $1.1B portfolio in Q2 2019.
  • GW Henssler & Associates opened 37 new positions and closed 42 in Q2 2019.
  • GW Henssler & Associates's portfolio value rose 1.2% quarter-over-quarter to $1.1B.

Based on GW Henssler & Associates's 13F filing for Q2 2019, filed 5 Aug 2019.